"I am very proud of the Episurf team today, and I would like to congratulate Prof. Ryd on this great achievement. Our history of strong clinical documentation and a solid operational experience creates a compelling combination for the future. We have satisfied customers, patients and counter-parties in a growing number of geographies, and we know that we are a market leader in a growing segment within orthopaedics," says Pål Ryfors, CEO Episurf Medical.

"1,000 implants is a significant number. We are out of the cradle! As one of the founders of this endeavour, more than a decade ago, this is a cause for great satisfaction but also gratitude and relief. We can now say, for certain, that the Episurf technology delivers. The Episurf technology benefits hitherto unfulfilled needs. Finally, I would like to extend my gratitude to our shareholders for their support" says Prof. Leif Ryd, Senior Medical Advisor, Episurf Medical.